Insider Trading Alert - ATVI, RMD And ARRS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, May 30, 2014, 127 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $34.87 to $852,403,612.06.

Highlighted Stocks Traded by Insiders:

Activision Blizzard (ATVI) - FREE Research Report

Vivendi, who is Former 10% Owner at Activision Blizzard, sold 41.5 million shares at $20.54 on May 30, 2014. Following this transaction, the Former 10% Owner owned 41.5 million shares meaning that the stake was reduced by 50% with the 41.5 million-share transaction.

The shares most recently traded at $20.57, up $0.03, or 0.15% since the insider transaction. Historical insider transactions for Activision Blizzard go as follows:

  • 4-Week # shares sold: 29,624
  • 12-Week # shares sold: 29,624
  • 24-Week # shares sold: 36,175

The average volume for Activision Blizzard has been 6.2 million shares per day over the past 30 days. Activision Blizzard has a market cap of $14.8 billion and is part of the technology sector and computer software & services industry. Shares are up 16.38% year-to-date as of the close of trading on Friday.

Activision Blizzard, Inc. publishes online, personal computer (PC), video game console, handheld, mobile, and tablet games. The company operates through three segments: Activision, Blizzard, and Distribution. The stock currently has a dividend yield of 0.96%. The company has a P/E ratio of 21.8. Currently, there are 16 analysts who rate Activision Blizzard a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ATVI - FREE

TheStreet Quant Ratings rates Activision Blizzard as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, attractive valuation levels, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Activision Blizzard Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

ResMed (RMD) - FREE Research Report

Roberts Christopher G, who is Director at ResMed, sold 25,000 shares at $49.73 on May 30, 2014. Following this transaction, the Director owned 101,988 shares meaning that the stake was reduced by 19.69% with the 25,000-share transaction.

The shares most recently traded at $49.61, down $0.12, or 0.23% since the insider transaction. Historical insider transactions for ResMed go as follows:

  • 4-Week # shares sold: 9,290
  • 12-Week # shares sold: 9,290
  • 24-Week # shares sold: 61,077

The average volume for ResMed has been 957,300 shares per day over the past 30 days. ResMed has a market cap of $7.0 billion and is part of the health care sector and health services industry. Shares are up 6.35% year-to-date as of the close of trading on Friday.

ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The stock currently has a dividend yield of 1.99%. The company has a P/E ratio of 22.0. Currently, there are 4 analysts who rate ResMed a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RMD - FREE

TheStreet Quant Ratings rates ResMed as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full ResMed Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

ARRIS Group (ARRS) - FREE Research Report

McClelland Bruce William, who is President, Broadband Comm Grou at ARRIS Group, sold 10,000 shares at $32.50 on May 30, 2014. Following this transaction, the President, Broadband Comm Grou owned 91,605 shares meaning that the stake was reduced by 9.84% with the 10,000-share transaction.

The shares most recently traded at $32.87, up $0.37, or 1.13% since the insider transaction. Historical insider transactions for ARRIS Group go as follows:

  • 4-Week # shares sold: 40,000
  • 12-Week # shares sold: 42,955
  • 24-Week # shares bought: 4,100
  • 24-Week # shares sold: 66,955

The average volume for ARRIS Group has been 2.0 million shares per day over the past 30 days. ARRIS Group has a market cap of $4.7 billion and is part of the technology sector and telecommunications industry. Shares are up 35.5% year-to-date as of the close of trading on Friday.

ARRIS Group, Inc. provides media entertainment and data communications solutions in the United States and internationally. The company operates in two segments, Customer Premises Equipment and Network & Cloud. The company has a P/E ratio of 824.5. Currently, there are 6 analysts who rate ARRIS Group a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ARRS - FREE

TheStreet Quant Ratings rates ARRIS Group as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full ARRIS Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

UK GDP Hits Slowest Pace in Five Years as Cold Snap Hammers Construction

UK GDP Hits Slowest Pace in Five Years as Cold Snap Hammers Construction

Amazon Shares on Record Path, Challenging Apple as World's Biggest Company

Amazon Shares on Record Path, Challenging Apple as World's Biggest Company

Global Stocks Rise on Tech Resurgence; Dollar Past 3-Month High Ahead of Q1 GDP

Global Stocks Rise on Tech Resurgence; Dollar Past 3-Month High Ahead of Q1 GDP

Daimler Shares Rise After Record Mercedes-Benz Sales, Bullish Profit Outlook

Daimler Shares Rise After Record Mercedes-Benz Sales, Bullish Profit Outlook

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI